Skip to main content

The Qian Lab Publishes In Nature Reviews Molecular Cell Biology

February 25, 2021
Congratulations to Li Qian, Ph.D., Associate Professor, Department of Pathology and Laboratory Medicine, and her team for publishing an invited long review article, titled “Direct cell reprogramming: approaches, mechanisms and progress”, in the prestigious Nature Reviews Molecular Cell Biology. Their work is featured in the February 22, 2021 issue of...

Li Qian, Ph.D. Received Emerging Investigator Award (EIA) R35 Grant From The National Institutes Of Health (NIH)

January 25, 2021
Congratulations to Li Qian, Ph.D., Associate Professor, Department of Pathology and Laboratory Medicine, for the receipt of EIA R35 grant from NIH’s NHLBI. The grant is to support the Qian Lab’s continued effort in further developing and refining reprogramming approaches to repair injured hearts. It is a 7-year grant for...

Jiandong Liu, Ph.D. And Li Qian, Ph.D. Both Awarded 2020 Established Investigator Award (EIA) From the American Heart Association (AHA)

November 2, 2020
Congratulations to Jiandong Liu, Ph.D., Associate Professor, & Li Qian, Ph.D., Associate Professor, both in the Department of Pathology and Laboratory Medicine, for the receipt of 2020 EIAs from the AHA. Drs. Liu & Qian feel honored and grateful to receive this award separately in the same year, particularly given the...

The Qian Lab Publishes In Science Translational Medicine

November 2, 2020
Congratulations to the lab of Li Qian, Ph.D., Associate Professor, Department of Pathology and Laboratory Medicine, for publishing article, titled “Down-regulation of Beclin1 promotes direct cardiac reprogramming”, in Science Translational Medicine. Their work is featured in the October 21, 2020 edition of Science Translational Medicine and can be read online...